Cocaine	B:C0009170
Use	O
Reverses	O
Striatal	O
Plasticity	I:C0027880
Produced	O
During	O
Cocaine	O
Seeking	O
.	O

Cocaine	O
Use	O
Reverses	O
Striatal	B:C0027880
Plasticity	I:C0027880
Produced	O
During	O
Cocaine	O
Seeking	O
.	O

Cocaine	O
Use	O
Reverses	O
Striatal	O
Plasticity	I:C0027880
Produced	O
During	O
Cocaine	B:C0009170
Seeking	O
.	O

Relapse	O
is	O
a	O
two	O
-	O
component	O
process	O
consisting	O
of	O
a	O
highly	O
motivated	B:C0026605
drug	O
-	O
seeking	O
phase	O
that	O
,	O
if	O
successful	O
,	O
is	O
followed	O
by	O
a	O
drug	O
-	I:C0242510
using	I:C0242510
phase	O
resulting	O
in	O
temporary	O
satiation	O
.	O

Relapse	O
is	O
a	O
two	O
-	O
component	O
process	O
consisting	O
of	O
a	O
highly	O
motivated	O
drug	O
-	O
seeking	O
phase	O
that	O
,	O
if	O
successful	O
,	O
is	O
followed	O
by	O
a	O
drug	B:C0242510
-	I:C0242510
using	I:C0242510
phase	O
resulting	O
in	O
temporary	O
satiation	O
.	O

Relapse	O
is	O
a	O
two	O
-	O
component	O
process	O
consisting	O
of	O
a	O
highly	O
motivated	O
drug	O
-	O
seeking	O
phase	O
that	O
,	O
if	O
successful	O
,	O
is	O
followed	O
by	O
a	O
drug	O
-	I:C0242510
using	I:C0242510
phase	O
resulting	O
in	O
temporary	O
satiation	B:C0036239
.	O

In	O
rodents	B:C0035804
,	O
cue	O
-	O
induced	O
drug	O
seeking	O
requires	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
(	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
)	O
of	O
cortical	O
glutamatergic	I:C0039062
synapses	I:C0039062
on	O
nucleus	O
accumbens	I:C0028633
core	O
medium	O
spiny	I:C0682698
neurons	I:C0682698
,	O
but	O
it	O
is	O
unknown	O
how	O
achieving	O
drug	O
use	I:C0242510
affects	O
this	O
plasticity	O
.	O

In	O
rodents	O
,	O
cue	O
-	O
induced	O
drug	O
seeking	O
requires	O
transient	B:C0206249
synaptic	I:C0206249
potentiation	I:C0206249
(	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
)	O
of	O
cortical	O
glutamatergic	I:C0039062
synapses	I:C0039062
on	O
nucleus	O
accumbens	I:C0028633
core	O
medium	O
spiny	I:C0682698
neurons	I:C0682698
,	O
but	O
it	O
is	O
unknown	O
how	O
achieving	O
drug	O
use	I:C0242510
affects	O
this	O
plasticity	O
.	O

In	O
rodents	O
,	O
cue	O
-	O
induced	O
drug	O
seeking	O
requires	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
(	O
transient	B:C0206249
synaptic	I:C0206249
potentiation	I:C0206249
)	O
of	O
cortical	O
glutamatergic	I:C0039062
synapses	I:C0039062
on	O
nucleus	O
accumbens	I:C0028633
core	O
medium	O
spiny	I:C0682698
neurons	I:C0682698
,	O
but	O
it	O
is	O
unknown	O
how	O
achieving	O
drug	O
use	I:C0242510
affects	O
this	O
plasticity	O
.	O

In	O
rodents	O
,	O
cue	O
-	O
induced	O
drug	O
seeking	O
requires	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
(	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
)	O
of	O
cortical	B:C0039062
glutamatergic	I:C0039062
synapses	I:C0039062
on	O
nucleus	O
accumbens	I:C0028633
core	O
medium	O
spiny	I:C0682698
neurons	I:C0682698
,	O
but	O
it	O
is	O
unknown	O
how	O
achieving	O
drug	O
use	I:C0242510
affects	O
this	O
plasticity	O
.	O

In	O
rodents	O
,	O
cue	O
-	O
induced	O
drug	O
seeking	O
requires	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
(	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
)	O
of	O
cortical	O
glutamatergic	I:C0039062
synapses	I:C0039062
on	O
nucleus	B:C0028633
accumbens	I:C0028633
core	O
medium	O
spiny	I:C0682698
neurons	I:C0682698
,	O
but	O
it	O
is	O
unknown	O
how	O
achieving	O
drug	O
use	I:C0242510
affects	O
this	O
plasticity	O
.	O

In	O
rodents	O
,	O
cue	O
-	O
induced	O
drug	O
seeking	O
requires	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
(	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
)	O
of	O
cortical	O
glutamatergic	I:C0039062
synapses	I:C0039062
on	O
nucleus	O
accumbens	I:C0028633
core	B:C0444669
medium	O
spiny	I:C0682698
neurons	I:C0682698
,	O
but	O
it	O
is	O
unknown	O
how	O
achieving	O
drug	O
use	I:C0242510
affects	O
this	O
plasticity	O
.	O

In	O
rodents	O
,	O
cue	O
-	O
induced	O
drug	O
seeking	O
requires	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
(	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
)	O
of	O
cortical	O
glutamatergic	I:C0039062
synapses	I:C0039062
on	O
nucleus	O
accumbens	I:C0028633
core	O
medium	B:C0682698
spiny	I:C0682698
neurons	I:C0682698
,	O
but	O
it	O
is	O
unknown	O
how	O
achieving	O
drug	O
use	I:C0242510
affects	O
this	O
plasticity	O
.	O

In	O
rodents	O
,	O
cue	O
-	O
induced	O
drug	O
seeking	O
requires	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
(	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
)	O
of	O
cortical	O
glutamatergic	I:C0039062
synapses	I:C0039062
on	O
nucleus	O
accumbens	I:C0028633
core	O
medium	O
spiny	I:C0682698
neurons	I:C0682698
,	O
but	O
it	O
is	O
unknown	O
how	O
achieving	O
drug	B:C0242510
use	I:C0242510
affects	O
this	O
plasticity	O
.	O

In	O
rodents	O
,	O
cue	O
-	O
induced	O
drug	O
seeking	O
requires	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
(	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
)	O
of	O
cortical	O
glutamatergic	I:C0039062
synapses	I:C0039062
on	O
nucleus	O
accumbens	I:C0028633
core	O
medium	O
spiny	I:C0682698
neurons	I:C0682698
,	O
but	O
it	O
is	O
unknown	O
how	O
achieving	O
drug	O
use	I:C0242510
affects	B:C0001721
this	O
plasticity	O
.	O

In	O
rodents	O
,	O
cue	O
-	O
induced	O
drug	O
seeking	O
requires	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
(	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
)	O
of	O
cortical	O
glutamatergic	I:C0039062
synapses	I:C0039062
on	O
nucleus	O
accumbens	I:C0028633
core	O
medium	O
spiny	I:C0682698
neurons	I:C0682698
,	O
but	O
it	O
is	O
unknown	O
how	O
achieving	O
drug	O
use	I:C0242510
affects	O
this	O
plasticity	B:C0027880
.	O

We	O
modeled	O
the	O
two	O
phases	O
of	O
relapse	O
after	O
extinction	B:C0015347
from	O
cocaine	O
self	O
-	I:C0036589
administration	I:C0036589
to	O
assess	O
how	O
cocaine	O
use	O
affects	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
associated	O
with	O
cue	O
-	O
induced	O
drug	O
seeking	O
.	O

We	O
modeled	O
the	O
two	O
phases	O
of	O
relapse	O
after	O
extinction	O
from	O
cocaine	B:C0009170
self	O
-	I:C0036589
administration	I:C0036589
to	O
assess	O
how	O
cocaine	O
use	O
affects	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
associated	O
with	O
cue	O
-	O
induced	O
drug	O
seeking	O
.	O

We	O
modeled	O
the	O
two	O
phases	O
of	O
relapse	O
after	O
extinction	O
from	O
cocaine	O
self	B:C0036589
-	I:C0036589
administration	I:C0036589
to	O
assess	O
how	O
cocaine	O
use	O
affects	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
associated	O
with	O
cue	O
-	O
induced	O
drug	O
seeking	O
.	O

We	O
modeled	O
the	O
two	O
phases	O
of	O
relapse	O
after	O
extinction	O
from	O
cocaine	O
self	O
-	I:C0036589
administration	I:C0036589
to	O
assess	O
how	O
cocaine	B:C0009170
use	O
affects	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
associated	O
with	O
cue	O
-	O
induced	O
drug	O
seeking	O
.	O

We	O
modeled	O
the	O
two	O
phases	O
of	O
relapse	O
after	O
extinction	O
from	O
cocaine	O
self	O
-	I:C0036589
administration	I:C0036589
to	O
assess	O
how	O
cocaine	O
use	O
affects	B:C0001721
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
associated	O
with	O
cue	O
-	O
induced	O
drug	O
seeking	O
.	O

We	O
modeled	O
the	O
two	O
phases	O
of	O
relapse	O
after	O
extinction	O
from	O
cocaine	O
self	O
-	I:C0036589
administration	I:C0036589
to	O
assess	O
how	O
cocaine	O
use	O
affects	O
transient	B:C0206249
synaptic	I:C0206249
potentiation	I:C0206249
associated	O
with	O
cue	O
-	O
induced	O
drug	O
seeking	O
.	O

Rats	B:C0034721
were	O
trained	O
to	O
self	O
-	I:C0036589
administer	I:C0036589
cocaine	O
(	O
n	O
=	O
96	O
)	O
or	O
were	O
used	O
as	O
yoked	O
-	O
saline	O
control	O
animals	I:C1511501
(	O
n	O
=	O
21	O
)	O
.	O

Rats	O
were	O
trained	O
to	O
self	B:C0036589
-	I:C0036589
administer	I:C0036589
cocaine	O
(	O
n	O
=	O
96	O
)	O
or	O
were	O
used	O
as	O
yoked	O
-	O
saline	O
control	O
animals	I:C1511501
(	O
n	O
=	O
21	O
)	O
.	O

Rats	O
were	O
trained	O
to	O
self	O
-	I:C0036589
administer	I:C0036589
cocaine	B:C0009170
(	O
n	O
=	O
96	O
)	O
or	O
were	O
used	O
as	O
yoked	O
-	O
saline	O
control	O
animals	I:C1511501
(	O
n	O
=	O
21	O
)	O
.	O

Rats	O
were	O
trained	O
to	O
self	O
-	I:C0036589
administer	I:C0036589
cocaine	O
(	O
n	O
=	O
96	O
)	O
or	O
were	O
used	O
as	O
yoked	O
-	O
saline	O
control	B:C1511501
animals	I:C1511501
(	O
n	O
=	O
21	O
)	O
.	O

After	O
extinction	B:C0015347
,	O
reinstatement	O
was	O
initiated	O
by	O
10	O
minutes	O
of	O
cue	O
-	O
induced	O
drug	O
seeking	O
,	O
followed	O
by	O
45	O
minutes	O
with	O
contingent	O
cocaine	O
access	O
,	O
after	O
which	O
cocaine	O
was	O
discontinued	O
and	O
unreinforced	O
lever	I:C0243095
pressing	I:C0243095
ensued	I:C0243095
.	O

After	O
extinction	O
,	O
reinstatement	O
was	O
initiated	O
by	O
10	O
minutes	O
of	O
cue	O
-	O
induced	O
drug	O
seeking	O
,	O
followed	O
by	O
45	O
minutes	O
with	O
contingent	O
cocaine	B:C0009170
access	O
,	O
after	O
which	O
cocaine	O
was	O
discontinued	O
and	O
unreinforced	O
lever	I:C0243095
pressing	I:C0243095
ensued	I:C0243095
.	O

After	O
extinction	O
,	O
reinstatement	O
was	O
initiated	O
by	O
10	O
minutes	O
of	O
cue	O
-	O
induced	O
drug	O
seeking	O
,	O
followed	O
by	O
45	O
minutes	O
with	O
contingent	O
cocaine	O
access	O
,	O
after	O
which	O
cocaine	B:C0009170
was	O
discontinued	O
and	O
unreinforced	O
lever	I:C0243095
pressing	I:C0243095
ensued	I:C0243095
.	O

After	O
extinction	O
,	O
reinstatement	O
was	O
initiated	O
by	O
10	O
minutes	O
of	O
cue	O
-	O
induced	O
drug	O
seeking	O
,	O
followed	O
by	O
45	O
minutes	O
with	O
contingent	O
cocaine	O
access	O
,	O
after	O
which	O
cocaine	O
was	O
discontinued	B:C1444662
and	O
unreinforced	O
lever	I:C0243095
pressing	I:C0243095
ensued	I:C0243095
.	O

After	O
extinction	O
,	O
reinstatement	O
was	O
initiated	O
by	O
10	O
minutes	O
of	O
cue	O
-	O
induced	O
drug	O
seeking	O
,	O
followed	O
by	O
45	O
minutes	O
with	O
contingent	O
cocaine	O
access	O
,	O
after	O
which	O
cocaine	O
was	O
discontinued	O
and	O
unreinforced	B:C0243095
lever	I:C0243095
pressing	I:C0243095
ensued	I:C0243095
.	O

Three	O
measures	O
of	O
transient	B:C0206249
synaptic	I:C0206249
potentiation	I:C0206249
were	O
assayed	O
during	O
reinstatement	O
:	O
dendritic	O
spine	I:C0872341
morphology	O
,	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
(	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
)	O
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
(	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
)	O
ratios	O
,	O
and	O
matrix	O
metalloproteinase	I:C0025543
activity	O
.	O

Three	O
measures	O
of	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
were	O
assayed	B:C1510438
during	O
reinstatement	O
:	O
dendritic	O
spine	I:C0872341
morphology	O
,	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
(	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
)	O
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
(	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
)	O
ratios	O
,	O
and	O
matrix	O
metalloproteinase	I:C0025543
activity	O
.	O

Three	O
measures	O
of	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
were	O
assayed	O
during	O
reinstatement	O
:	O
dendritic	B:C0872341
spine	I:C0872341
morphology	O
,	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
(	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
)	O
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
(	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
)	O
ratios	O
,	O
and	O
matrix	O
metalloproteinase	I:C0025543
activity	O
.	O

Three	O
measures	O
of	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
were	O
assayed	O
during	O
reinstatement	O
:	O
dendritic	O
spine	I:C0872341
morphology	O
,	O
alpha	B:C0051318
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
(	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
)	O
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
(	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
)	O
ratios	O
,	O
and	O
matrix	O
metalloproteinase	I:C0025543
activity	O
.	O

Three	O
measures	O
of	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
were	O
assayed	O
during	O
reinstatement	O
:	O
dendritic	O
spine	I:C0872341
morphology	O
,	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
(	O
alpha	B:C0051318
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
)	O
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
(	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
)	O
ratios	O
,	O
and	O
matrix	O
metalloproteinase	I:C0025543
activity	O
.	O

Three	O
measures	O
of	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
were	O
assayed	O
during	O
reinstatement	O
:	O
dendritic	O
spine	I:C0872341
morphology	O
,	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
(	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
)	O
to	O
N	B:C0079883
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
(	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
)	O
ratios	O
,	O
and	O
matrix	O
metalloproteinase	I:C0025543
activity	O
.	O

Three	O
measures	O
of	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
were	O
assayed	O
during	O
reinstatement	O
:	O
dendritic	O
spine	I:C0872341
morphology	O
,	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
(	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
)	O
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
(	O
N	B:C0079883
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
)	O
ratios	O
,	O
and	O
matrix	O
metalloproteinase	I:C0025543
activity	O
.	O

Three	O
measures	O
of	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
were	O
assayed	O
during	O
reinstatement	O
:	O
dendritic	O
spine	I:C0872341
morphology	O
,	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
(	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
)	O
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
(	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
)	O
ratios	O
,	O
and	O
matrix	B:C0025543
metalloproteinase	I:C0025543
activity	O
.	O

Three	O
measures	O
of	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
were	O
assayed	O
during	O
reinstatement	O
:	O
dendritic	O
spine	I:C0872341
morphology	O
,	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
(	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
)	O
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
(	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
)	O
ratios	O
,	O
and	O
matrix	O
metalloproteinase	I:C0025543
activity	B:C0243102
.	O

We	O
found	B:C0243095
that	O
cocaine	O
use	O
for	O
10	O
minutes	O
collapsed	O
all	O
three	O
measures	O
of	O
cue-	O
potentiated	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
back	O
to	O
baseline	O
.	O

We	O
found	O
that	O
cocaine	B:C0009170
use	O
for	O
10	O
minutes	O
collapsed	O
all	O
three	O
measures	O
of	O
cue-	O
potentiated	O
transient	O
synaptic	I:C0206249
potentiation	I:C0206249
back	O
to	O
baseline	O
.	O

We	O
found	O
that	O
cocaine	O
use	O
for	O
10	O
minutes	O
collapsed	O
all	O
three	O
measures	O
of	O
cue-	O
potentiated	O
transient	B:C0206249
synaptic	I:C0206249
potentiation	I:C0206249
back	O
to	O
baseline	O
.	O

Moreover	O
,	O
when	O
cocaine	B:C0009170
use	O
was	O
discontinued	O
45	O
minutes	O
later	O
,	O
dendritic	O
spine	I:C0872341
morphology	O
and	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
ratios	O
were	O
restored	O
as	O
animals	O
became	O
motivated	O
to	O
engage	O
unrewarded	O
lever	O
pressing	I:C0243095
.	O

Moreover	O
,	O
when	O
cocaine	O
use	O
was	O
discontinued	B:C1444662
45	O
minutes	O
later	O
,	O
dendritic	O
spine	I:C0872341
morphology	O
and	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
ratios	O
were	O
restored	O
as	O
animals	O
became	O
motivated	O
to	O
engage	O
unrewarded	O
lever	O
pressing	I:C0243095
.	O

Moreover	O
,	O
when	O
cocaine	O
use	O
was	O
discontinued	O
45	O
minutes	O
later	O
,	O
dendritic	B:C0872341
spine	I:C0872341
morphology	O
and	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
ratios	O
were	O
restored	O
as	O
animals	O
became	O
motivated	O
to	O
engage	O
unrewarded	O
lever	O
pressing	I:C0243095
.	O

Moreover	O
,	O
when	O
cocaine	O
use	O
was	O
discontinued	O
45	O
minutes	O
later	O
,	O
dendritic	O
spine	I:C0872341
morphology	O
and	O
alpha	B:C0051318
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
ratios	O
were	O
restored	O
as	O
animals	O
became	O
motivated	O
to	O
engage	O
unrewarded	O
lever	O
pressing	I:C0243095
.	O

Moreover	O
,	O
when	O
cocaine	O
use	O
was	O
discontinued	O
45	O
minutes	O
later	O
,	O
dendritic	O
spine	I:C0872341
morphology	O
and	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
to	O
N	B:C0079883
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
ratios	O
were	O
restored	O
as	O
animals	O
became	O
motivated	O
to	O
engage	O
unrewarded	O
lever	O
pressing	I:C0243095
.	O

Moreover	O
,	O
when	O
cocaine	O
use	O
was	O
discontinued	O
45	O
minutes	O
later	O
,	O
dendritic	O
spine	I:C0872341
morphology	O
and	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
ratios	O
were	O
restored	O
as	O
animals	B:C0003062
became	O
motivated	O
to	O
engage	O
unrewarded	O
lever	O
pressing	I:C0243095
.	O

Moreover	O
,	O
when	O
cocaine	O
use	O
was	O
discontinued	O
45	O
minutes	O
later	O
,	O
dendritic	O
spine	I:C0872341
morphology	O
and	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
ratios	O
were	O
restored	O
as	O
animals	O
became	O
motivated	B:C0026605
to	O
engage	O
unrewarded	O
lever	O
pressing	I:C0243095
.	O

Moreover	O
,	O
when	O
cocaine	O
use	O
was	O
discontinued	O
45	O
minutes	O
later	O
,	O
dendritic	O
spine	I:C0872341
morphology	O
and	O
alpha	O
-	I:C0051318
amino	I:C0051318
-	I:C0051318
3	I:C0051318
-	I:C0051318
hydroxy	I:C0051318
-	I:C0051318
5	I:C0051318
-	I:C0051318
methyl	I:C0051318
-	I:C0051318
4	I:C0051318
-	I:C0051318
isoxazole	I:C0051318
propionic	I:C0051318
acid	I:C0051318
to	O
N	O
-	I:C0079883
methyl	I:C0079883
-	I:C0079883
D-	I:C0079883
aspartate	I:C0079883
ratios	O
were	O
restored	O
as	O
animals	O
became	O
motivated	O
to	O
engage	O
unrewarded	O
lever	B:C0243095
pressing	I:C0243095
.	O

Nonreinforced	O
drug	O
seeking	O
was	O
positively	B:C1446409
correlated	O
with	O
changes	O
in	O
spine	O
morphology	O
,	O
and	O
cocaine	O
access	O
reversed	O
this	O
relationship	O
.	O

Nonreinforced	O
drug	O
seeking	O
was	O
positively	O
correlated	O
with	O
changes	O
in	O
spine	B:C2752558
morphology	O
,	O
and	O
cocaine	O
access	O
reversed	O
this	O
relationship	O
.	O

Nonreinforced	O
drug	O
seeking	O
was	O
positively	O
correlated	O
with	O
changes	O
in	O
spine	O
morphology	O
,	O
and	O
cocaine	B:C0009170
access	O
reversed	O
this	O
relationship	O
.	O

Using	O
a	O
novel	O
modification	O
of	O
the	O
reinstatement	O
paradigm	O
,	O
we	O
show	O
that	O
achieving	O
cocaine	B:C0009170
use	O
reversed	O
the	O
synaptic	O
plasticity	O
underpinning	O
the	O
motivation	O
to	O
seek	O
the	O
drug	O
.	O

Using	O
a	O
novel	O
modification	O
of	O
the	O
reinstatement	O
paradigm	O
,	O
we	O
show	O
that	O
achieving	O
cocaine	O
use	O
reversed	O
the	O
synaptic	O
plasticity	O
underpinning	O
the	O
motivation	B:C0026605
to	O
seek	O
the	O
drug	O
.	O

Using	O
a	O
novel	O
modification	O
of	O
the	O
reinstatement	O
paradigm	O
,	O
we	O
show	O
that	O
achieving	O
cocaine	O
use	O
reversed	O
the	O
synaptic	O
plasticity	O
underpinning	O
the	O
motivation	O
to	O
seek	O
the	O
drug	B:C1254351
.	O

